Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer

NCT00862524 is registered in ClinicalTrials.gov with Array BioPharma as lead sponsor.

NCT NCT00862524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00862524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer
Lead sponsor
Array BioPharma
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2009
Completion date
February 28, 2011
Enrollment
20 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, pancreatic cancer